Pete A Williams

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 48

Top Venues

Acta neuropathologica communications

Neural regeneration research

Nature communications

Nature medicine

Karolinska Institutet

Cardiff University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Apr 16 2018

Sweden

Assistant Professor :: Department of Clinical Neuroscience

Jackson Laboratory - Apr 01 2018

United States

Postdoctoral Fellow

Education History

Cardiff University

United Kingdom

PHD :: School of Optometry and Vision Sciences

Publications

Gloria Cimaglia, James R Tribble, Marcela Votruba, Pete A Williams, James E Morgan
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma. Acta neuropathologica communications 12 (1) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
Bledi Petriti, Alessandro Rabiolo, Kai-Yin Chau, Pete A Williams, Giovanni Montesano, Gerassimos Lascaratos, David F Garway-Heath
Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nature medicine 30 (8) (2024)
Alessio Canovai, Pete A Williams
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism. Neural regeneration research 20 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Anne Rombaut, Danica Jovancevic, Raymond Ching-Bong Wong, Alan Nicol, Rune Brautaset, David I Finkelstein, Christine T O Nguyen, James R Tribble, Pete A Williams
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection. Acta neuropathologica communications 12 (1) (2024)
Anne Rombaut, Danica Jovancevic, Raymond Ching-Bong Wong, Alan Nicol, Rune Brautaset, David I Finkelstein, Christine T O Nguyen, James R Tribble, Pete A Williams
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection. Acta neuropathologica communications 12 (1) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Anne Rombaut, Danica Jovancevic, Raymond Ching-Bong Wong, Alan Nicol, Rune Brautaset, David I Finkelstein, Christine T O Nguyen, James R Tribble, Pete A Williams
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection. Acta neuropathologica communications 12 (1) (2024)
Alessio Canovai, Pete A Williams
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism. Neural regeneration research 20 (1) (2024)
Alessio Canovai, Pete A Williams
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism. Neural regeneration research 20 (1) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Gloria Cimaglia, James R Tribble, Marcela Votruba, Pete A Williams, James E Morgan
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma. Acta neuropathologica communications 12 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
Bledi Petriti, Alessandro Rabiolo, Kai-Yin Chau, Pete A Williams, Giovanni Montesano, Gerassimos Lascaratos, David F Garway-Heath
Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nature medicine 30 (8) (2024)
Amin Otmani, Gauti Jóhannesson, Rune Brautaset, James R Tribble, Pete A Williams
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta neuropathologica communications 12 (1) (2024)
Bledi Petriti, Alessandro Rabiolo, Kai-Yin Chau, Pete A Williams, Giovanni Montesano, Gerassimos Lascaratos, David F Garway-Heath
Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nature medicine (2024)
Bledi Petriti, Alessandro Rabiolo, Kai-Yin Chau, Pete A Williams, Giovanni Montesano, Gerassimos Lascaratos, David F Garway-Heath
Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nature medicine 30 (8) (2024)
Alessio Canovai, James R Tribble, Melissa Jöe, Daniela Y Westerlund, Rosario Amato, Ian A Trounce, Massimo Dal Monte, Pete A Williams
Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection. Acta neuropathologica communications 11 (1) (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Pete A Williams, Robert J Casson
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma. Neural regeneration research 19 (8) (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Pete A Williams, Robert J Casson
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma. Neural regeneration research 19 (8) (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
Pete A Williams, Robert J Casson
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma. Neural regeneration research 19 (8) (2023)
James R Tribble, Anna Hagström, Kenza Jusseaume, Emma Lardner, Raymond Ching-Bong Wong, Gustav Stålhammar, Pete A Williams
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta neuropathologica communications 11 (1) (2023)
Pete A Williams, Robert J Casson
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma. Neural regeneration research 19 (8) (2023)
Carola Rutigliani, James R Tribble, Anna Hagström, Emma Lardner, Gauti Jóhannesson, Gustav Stålhammar, Pete A Williams
Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients. Acta neuropathologica communications 10 (1) (2022)
James R Tribble, Flora Hui, Melissa Jöe, Katharina Bell, Vicki Chrysostomou, Jonathan G Crowston, Pete A Williams
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma. Cells 10 (2) (2021)
Tim J Enz, James R Tribble, Pete A Williams
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection. Journal of clinical medicine 10 (17) (2021)
Bledi Petriti, Pete A Williams, Gerassimos Lascaratos, Kai-Yin Chau, David F Garway-Heath
Neuroprotection in Glaucoma: NAD+/NADH Redox State as a Potential Biomarker and Therapeutic Target. Cells 10 (6) (2021)
Jeffrey M Harder, Chelsea Guymer, John P M Wood, Evangelia Daskalaki, Glyn Chidlow, Chi Zhang, Revathi Balasubramanian, Brynn H Cardozo, Nicole E Foxworth, Kelly E Deering, Tionna B Ouellette, Christa Montgomery, Craig E Wheelock, Robert J Casson, Pete A Williams, Simon W M John
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin. Proceedings of the National Academy of Sciences of the United States of America 117 (52) (2020)
Jeffrey M Harder, Pete A Williams, Catherine E Braine, Hongtian S Yang, Jocelyn M Thomas, Nicole E Foxworth, Simon W M John, Gareth R Howell
Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice. Journal of neuroinflammation 17 (1) (2020)
Ryan J Bevan, Timothy R Hughes, Pete A Williams, Mark A Good, Bryan Paul Morgan, James E Morgan
Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer's disease. Acta neuropathologica communications 8 (1) (2020)
Flora Hui, Jessica Tang, Pete A Williams, Myra B McGuiness, Xavier Hadoux, Robert J Casson, Michael Coote, Ian A Trounce, Keith R Martin, Peter van Wijngaarden, Jonathan G Crowston
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial. Clinical & experimental ophthalmology 48 (7) (2020)
Veselina Petrova, Craig S Pearson, Jared Ching, James R Tribble, Andrea G Solano, Yunfei Yang, Fiona M Love, Robert J Watt, Andrew Osborne, Evan Reid, Pete A Williams, Keith R Martin, Herbert M Geller, Richard Eva, James W Fawcett
Protrudin functions from the endoplasmic reticulum to support axon regeneration in the adult CNS. Nature communications 11 (1) (2020)
Gloria Cimaglia, Marcela Votruba, James E Morgan, Helder André, Pete A Williams
Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration. Nutrients 12 (9) (2020)
Ryan J Bevan, Pete A Williams, Caroline T Waters, Rebecca Thirgood, Amanda Mui, Sharon Seto, Mark Good, James E Morgan, Marcela Votruba, Irina Erchova
OPA1 deficiency accelerates hippocampal synaptic remodelling and age-related deficits in learning and memory. Brain communications 2 (2) (2020)
Pete A Williams, Catherine E Braine, Krishnakumar Kizhatil, Nicole E Foxworth, Nicholas G Tolman, Jeffrey M Harder, Rebecca A Scott, Gregory L Sousa, Alyssa Panitch, Gareth R Howell, Simon W M John
Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma. Molecular neurodegeneration 14 (1) (2019)
James R Tribble, Asta Vasalauskaite, Tony Redmond, Robert D Young, Shoaib Hassan, Michael P Fautsch, Frank Sengpiel, Pete A Williams, James E Morgan
Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain communications 1 (1) (2019)
Jeffrey M Harder, Pete A Williams, Ileana Soto, Nicole E Foxworth, Kimberly A Fernandes, Nelson F Freeburg, Richard T Libby, Simon W M John
Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice. Cell death & disease 9 (6) (2018)
Helene Choquet, Seyyedhassan Paylakhi, Stephen C Kneeland, Khanh K Thai, Thomas J Hoffmann, Jie Yin, Mark N Kvale, Yambazi Banda, Nicholas G Tolman, Pete A Williams, Catherine Schaefer, Ronald B Melles, Neil Risch, Simon W M John, K Saidas Nair, Eric Jorgensen
A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci. Nature communications 9 (1) (2018)
Pete A Williams, Jeffrey M Harder, Nicole E Foxworth, Kelly E Cochran, Philipp P Henrich, Vittorio Porciatti, Oliver Smithies, Simon W M John
Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science (New York, N.Y.) 355 (6326) (2017)

Pete A Williams.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pete A Williams